{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:05:45Z","timestamp":1791403545832,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.brainres.2013.12.030","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T16:16:24Z","timestamp":1392048984000},"page":"43-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Rasagiline prevents neurodegeneration in thiamine deficient rats\u2014A longitudinal MRI study"],"prefix":"10.1016","volume":"1557","author":[{"given":"Vered","family":"Dror","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Rehavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal E","family":"Biton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Eliash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.12.030_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005072-198405000-00006","article-title":"Low energy levels in thiamine-deficient encephalopathy","volume":"43","author":"Aikawa","year":"1984","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.12.030_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1471-4159.2002.01047.x","article-title":"Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan","volume":"82","author":"Akao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.12.030_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1471-4159.2007.04777.x","article-title":"Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro","volume":"103","author":"Bar-Am.","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.12.030_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mrm.1910390610","article-title":"A simplified method to measure the diffusion tensor from seven MR images","volume":"39","author":"Basser","year":"1998","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.brainres.2013.12.030_bib7","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1046\/j.1471-4159.1995.65052178.x","article-title":"Thiamine deficiency--induced partial necrosis and mitochondrial uncoupling in neuroblastoma cells are rapidly reversed by addition of thiamine","volume":"65","author":"Bettendorff","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.12.030_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jnen\/59.3.207","article-title":"Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism","volume":"59","author":"Calingasan","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.12.030_bib9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","article-title":"Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson\u05f3s disease","volume":"29","author":"Chen","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.brainres.2013.12.030_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.WCB.0000100341.78607.EB","article-title":"Magnetic resonance imaging in experimental models of brain disorders","volume":"23","author":"Dijkhuizen","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2013.12.030_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2009.10.032","article-title":"Neurodegeneration in thiamine deficient rats\u2014a longitudinal MRI study","volume":"1308","author":"Dror","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.12.030_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s007020170012","article-title":"Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats","volume":"108","author":"Eliash","year":"2001","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2013.12.030_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00702-004-0254-4","article-title":"Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model","volume":"112","author":"Eliash","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2013.12.030_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2008.11.097","article-title":"Neuroprotection by rasagiline in thiamine deficient rats","volume":"1256","author":"Eliash","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.12.030_bib15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1089\/ars.2007.1766","article-title":"Thiamine-dependent processes and treatment strategies in neurodegeneration","volume":"9","author":"Gibson","year":"2007","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.brainres.2013.12.030_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1148\/radiol.2223010311","article-title":"Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter","volume":"222","author":"Guo","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.brainres.2013.12.030_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410130403","article-title":"Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency","volume":"13","author":"Hakim","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2013.12.030_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/alcalc\/agn120","article-title":"Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation","volume":"44","author":"Hazell","year":"2009","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.brainres.2013.12.030_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-4159.1993.tb03635.x","article-title":"Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency","volume":"61","author":"Hazell","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.12.030_bib200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(98)00929-7","article-title":"Neuroprotective effect of rasagiline, a selective monamine oxidase-B inhibitor, against closed head injury in the mouse","volume":"366","author":"Huang","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2013.12.030_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuint.2010.11.019","article-title":"Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism","volume":"58","author":"Jhala","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2013.12.030_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/nbm.1667","article-title":"MRI evaluation of axonal reorganization after bone marrow stromal cell treatment of traumatic brain injury","volume":"24","author":"Jiang","year":"2011","journal-title":"NMR Biomed."},{"key":"10.1016\/j.brainres.2013.12.030_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.brainres.2013.12.030_bib24","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1523\/JNEUROSCI.10-05-01664.1990","article-title":"Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain","volume":"10","author":"Langlais","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.030_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00996904","article-title":"Pyrithiamine-induced thiamine deficiency results in decreased Ca(2+)-dependent release of glutamate from rat hippocampal slices","volume":"6","author":"Le","year":"1991","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2013.12.030_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrn1119","article-title":"Looking into the functional architecture of the brain with diffusion MRI","volume":"4","author":"Le Bihan","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.030_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2004.12.027","article-title":"Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives","volume":"48","author":"Mandel","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.brainres.2013.12.030_bib28","first-page":"1233","article-title":"Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor","volume":"34","author":"Maruyama","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.12.030_bib29","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.brainres.2013.12.030_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-4328(00)00350-8","article-title":"Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent","volume":"119","author":"Pitkin","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.12.030_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3233\/JAD-2004-6S609","article-title":"New directions in neuroprotection: basic mechanisms, molecular targets and treatment strategies","volume":"6","author":"Refolo","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2013.12.030_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1099-1492(199904)12:2<69::AID-NBM548>3.0.CO;2-D","article-title":"In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives","volume":"12","author":"Rudin","year":"1999","journal-title":"NMR Biomed."},{"key":"10.1016\/j.brainres.2013.12.030_bib33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1471-4159.1996.67020684.x","article-title":"Regional reductions of transketolase in thiamine-deficient rat brain","volume":"67","author":"Sheu","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.12.030_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pnpbp.2013.02.001","article-title":"An update on amine oxidase inhibitors: multifaceted drugs","volume":"44","author":"Song.","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2013.12.030_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0091-3057(97)00603-5","article-title":"Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat","volume":"60","author":"Speiser","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2013.12.030_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s007020050182","article-title":"Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat","volume":"106","author":"Speiser","year":"1999","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2013.12.030_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00702-006-0612-5","article-title":"Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat","volume":"114","author":"Speiser","year":"2007","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2013.12.030_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archneur.1981.00510060052007","article-title":"Model of Wernicke\u05f3s encephalopathy","volume":"38","author":"Troncoso","year":"1981","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2013.12.030_bib39","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neuroscience.2006.10.008","article-title":"Thiamine deficiency induces endoplasmic reticulum stress in neurons","volume":"144","author":"Wang","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2013.12.030_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1196\/annals.1344.030","article-title":"Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway","volume":"1053","author":"Weinreb","year":"2005","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.brainres.2013.12.030_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2013.12.030_bib42","first-page":"450","article-title":"The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo","volume":"939","author":"Youdim","year":"2001"},{"key":"10.1016\/j.brainres.2013.12.030_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition","volume":"79","author":"Youdim","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2013.12.030_bib44","first-page":"369","article-title":"Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline","volume":"41","author":"Youdim","year":"2005"},{"key":"10.1016\/j.brainres.2013.12.030_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim.","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"S 1","key":"10.1016\/j.brainres.2013.12.030_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00415-008-1009-1","article-title":"The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome","volume":"255","author":"Zivadinov","year":"2008","journal-title":"J. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313016181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313016181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:51:27Z","timestamp":1565185887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313016181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":44,"alternative-id":["S0006899313016181"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.12.030","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rasagiline prevents neurodegeneration in thiamine deficient rats\u2014A longitudinal MRI study","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2013.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}